TY - JOUR AU - Kim, Seung Tae AU - Sa, Jason K. AU - Oh, Sung Yong AU - Kim, Kyung AU - Hong, Jung Yong AU - Kang, Won Ki AU - Kim, Kyoung-Mee AU - Lee, Jeeyun PY - 2021 DA - 2021/01/25 TI - Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial JO - Genome Medicine SP - 11 VL - 13 IS - 1 AB - Gastric cancer (GC) is a heterogenous disease consisted of several subtypes with distinct molecular traits. The clinical implication of molecular classification has been limited especially in association with treatment efficacy of ramucirumab or various targeted agents. SN - 1756-994X UR - https://doi.org/10.1186/s13073-021-00826-w DO - 10.1186/s13073-021-00826-w ID - Kim2021 ER -